TILS.L Share News (TILS)
TILS Share
TILS Share
TILS Share
TILS Share
TILS
TILS Share
TILS Broker
TILS Directors
TILS Financial
TILS
TILS Short
TILSFri, 17th Aug 2018 11:39
LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth GBP214,495.
Panetta acquired 469,766 shares for an average price 49 pence each in five separate transactions on Thursday.
As a result of the transactions, Cerrone now owns 64.2 million shares representing 50.55% of the company.
Shares in the biotechnology company were trading 26% higher at 72.50p each.
Tiziana Life Sciences has been granted an exclusive license to develop and commercialise Novimmune SA's CD3 receptor monoclonal antibody foralumab. Foralumab can be utilised for a range of autoimmune and inflammatory diseases, such multiple sclerosis, type-1 diabetes, inflammatory bowel disease, pso
Read more